These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 10462038
1. Insulin-like growth factor-II expression is down-regulated in TrkA-transfected SK-N-AS neuroblastoma cells. Kim CJ, Chi JG, Thiele CJ. Lab Invest; 1999 Aug; 79(8):1007-13. PubMed ID: 10462038 [Abstract] [Full Text] [Related]
2. Regulation of NGF responsiveness in human neuroblastoma. Bogenmann E, Peterson S, Maekawa K, Matsushima H. Oncogene; 1998 Nov 05; 17(18):2367-76. PubMed ID: 9811468 [Abstract] [Full Text] [Related]
3. Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II. El-Badry OM, Romanus JA, Helman LJ, Cooper MJ, Rechler MM, Israel MA. J Clin Invest; 1989 Sep 05; 84(3):829-39. PubMed ID: 2547840 [Abstract] [Full Text] [Related]
4. NGF induces terminal differentiation in trkA expressing neuroblastoma cells in vitro and in vivo. Matsushima H, Bogenmann E. Prog Clin Biol Res; 1994 Sep 05; 385():177-83. PubMed ID: 7972210 [No Abstract] [Full Text] [Related]
5. N-myc regulation of type I insulin-like growth factor receptor in a human neuroblastoma cell line. Chambéry D, Mohseni-Zadeh S, de Gallé B, Babajko S. Cancer Res; 1999 Jun 15; 59(12):2898-902. PubMed ID: 10383152 [Abstract] [Full Text] [Related]
6. TrkA neurogenic receptor regulates differentiation of neuroblastoma cells. Poluha W, Poluha DK, Ross AH. Oncogene; 1995 Jan 05; 10(1):185-9. PubMed ID: 7824271 [Abstract] [Full Text] [Related]
7. The RET and TRKA pathways collaborate to regulate neuroblastoma differentiation. Peterson S, Bogenmann E. Oncogene; 2004 Jan 08; 23(1):213-25. PubMed ID: 14712226 [Abstract] [Full Text] [Related]
8. Expression and function of the nerve growth factor receptor (TRK-A) in human neuroblastoma cell lines. Azar CG, Scavarda NJ, Nakagawara A, Brodeur GM. Prog Clin Biol Res; 1994 Jan 08; 385():169-75. PubMed ID: 7972209 [Abstract] [Full Text] [Related]
9. Transfection of TRK-A into human neuroblastoma cells restores their ability to differentiate in response to nerve growth factor. Lavenius E, Gestblom C, Johansson I, Nånberg E, Påhlman S. Cell Growth Differ; 1995 Jun 08; 6(6):727-36. PubMed ID: 7669728 [Abstract] [Full Text] [Related]
10. Insulin-like growth factor II-mediated proliferation of human neuroblastoma. El-Badry OM, Helman LJ, Chatten J, Steinberg SM, Evans AE, Israel MA. J Clin Invest; 1991 Feb 08; 87(2):648-57. PubMed ID: 1991849 [Abstract] [Full Text] [Related]
11. Up-regulation of insulin-like growth factor-II expression is a feature of TrkA but not TrkB activation in SH-SY5Y neuroblastoma cells. Kim CJ, Matsuo T, Lee KH, Thiele CJ. Am J Pathol; 1999 Nov 08; 155(5):1661-70. PubMed ID: 10550322 [Abstract] [Full Text] [Related]
12. Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis. Kogner P, Barbany G, Dominici C, Castello MA, Raschellá G, Persson H. Cancer Res; 1993 May 01; 53(9):2044-50. PubMed ID: 8481906 [Abstract] [Full Text] [Related]
13. Insulin-like growth factor II messenger ribonucleic acid expression in Wilms tumor, nephrogenic rest, and kidney. Yun K, Molenaar AJ, Fiedler AM, Mark AJ, Eccles MR, Becroft DM, Reeve AE. Lab Invest; 1993 Nov 01; 69(5):603-15. PubMed ID: 7504120 [Abstract] [Full Text] [Related]
14. Trk mRNA and low affinity nerve growth factor receptor mRNA expression and triploid DNA content in favorable neuroblastoma tumors. Kogner P, Barbany G, Björk O, Castello MA, Donfrancesco A, Falkmer UG, Hedborg F, Kouvidou H, Persson H, Raschella G. Prog Clin Biol Res; 1994 Nov 01; 385():137-45. PubMed ID: 7972205 [Abstract] [Full Text] [Related]
15. Expression of TrkC in favorable human neuroblastomas. Yamashiro DJ, Nakagawara A, Ikegaki N, Liu XG, Brodeur GM. Oncogene; 1996 Jan 04; 12(1):37-41. PubMed ID: 8552397 [Abstract] [Full Text] [Related]
16. Cotransfection of TrkA and p75(NTR) in neuroblastoma cell line (IMR-32) promotes differentiation and apoptosis of tumor cells. Chen J, Zhe X. Chin Med J (Engl); 2003 Jun 04; 116(6):906-12. PubMed ID: 12877805 [Abstract] [Full Text] [Related]
17. Down-regulation of insulin-like growth factor I receptor activity by NVP-AEW541 has an antitumor effect on neuroblastoma cells in vitro and in vivo. Tanno B, Mancini C, Vitali R, Mancuso M, McDowell HP, Dominici C, Raschellà G. Clin Cancer Res; 2006 Nov 15; 12(22):6772-80. PubMed ID: 17121898 [Abstract] [Full Text] [Related]
18. Insulin-like growth factor I receptor prevents apoptosis and enhances neuroblastoma tumorigenesis. Singleton JR, Randolph AE, Feldman EL. Cancer Res; 1996 Oct 01; 56(19):4522-9. PubMed ID: 8813151 [Abstract] [Full Text] [Related]
19. Induction of N-myc in neuroblastoma by autocrine IGF-II depends on farnesylated Ras. Application of farnesyltransferase inhibitors. Wittrock J, Schweizer P, Girgert R. Anticancer Res; 2002 Oct 01; 22(6C):4205-9. PubMed ID: 12553057 [Abstract] [Full Text] [Related]
20. Expression of functional trk tyrosine kinase receptors after T cell activation. Ehrhard PB, Erb P, Graumann U, Schmutz B, Otten U. J Immunol; 1994 Mar 15; 152(6):2705-9. PubMed ID: 8144877 [Abstract] [Full Text] [Related] Page: [Next] [New Search]